Jingwei Liu, M.D.

Peer-Reviewed Articles

1. Fuliang Chu, Haiyan Li, Xindong Liu, Jingjing Cao, Wencai Ma, Ying Ma, Jinsheng Weng, Zheng Zhu, Xiaoyun Cheng, Zhiqiang Wang, Jingwei Liu, Zi Yang Jiang, Amber U. Luong, Weiyi Peng, Jing Wang, Kumudha Balakrishnan, Cassian Yee, Chen Dong, Richard Eric Davis, Stephanie S Watowich & 1 others. CXCR5 + CD8 + T cells are a distinct functional subset with an antitumor activity. Leukemia, 2019.
2. Ge G1,2, Chen C1, Guderyon MJ1, Liu J1, He Z2, Yu Y2, Clark RA1,3, Li S. Regulatable Lentiviral Hematopoietic Stem Cell Gene Therapy in a Mouse Model of Parkinson's Disease. Stem Cells Dev, 2018.
3. Chen C1, Li X1, Ge G1, Liu J1, Biju KC1, Laing SD1, Qian Y1, Ballard C1, He Z2, Masliah E3, Clark RA1,4, O'Connor JC5,6, Li S. GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice. scientific Reports, 2018.
4. Elisabetta Damiani, Nahum Puebla-Osorio, Bree M. Lege, Jingwei Liu, Sattva S. Neelapu & Stephen E. Ullric. Platelet activating factor-induced expression of p21 is correlated with histone acetylation. Scientific Reports, 2017.
5. .Linlin Cong, Eric R. Muir ,Cang Chen, Yusheng Qian, Jingwei Liu, K. C. Biju, Robert A. Clark, Senlin Li, Timothy Q. Duong. Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson’s Disease. PLoS One, 2016.

Abstracts

1. Fuliang Chu, JingJing Cao, Jingwei Liu, Xiaoyun Cheng, Swathi Karri, Adithi Reddy, Shao Qing Kuang, Jinsheng Weng, Sattva S. Neelapu. Targeting CAR T resistance due to CD19 loss with CD79b-specific CAR T cells in B-cell malignancies. Blood, 2018.
2. Aidi Gu, Huaxian Ma, Xiaorui Zhang, Prerna Malaney, Miguel Gallardo, Jingwei Liu, Sattva S. Neelapu and Sean M Post. Combination Therapy with BTK Inhibitor Plus Anti-PD-1 Antibody Results in a Hyperprogressor Phenotype in a Mouse Model of CLL. Blood, 2018.